Friday, May 20, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

certification

Havana, Mar 28 (Prensa Latina) NeuroEPO, Cuba's neuroprotective drug to counteract mild and moderate Alzheimer's disease, concluded phase II/III studies and a stage IV of progressive introduction of the product is being prepared, a scientific authority noted on Monday.